Bio Peptides Labs®Your research. Our focus.
Cart 0
Retatrutide (GLP3-R) 20mg research vial mockup

Illustrative label mockup. Lot # xxxxxx is a placeholder; the supplied vial carries its assigned lot number.

Research peptide

In stock

Retatrutide (GLP3-R) 20mg

Lyophilized research peptide. 20 mg per vial. For laboratory research only.

Purchase details

Selected strength20 mg
AvailabilityIn stock
Catalog price$69.99
Tracked shippingUSPS
ShippingFree at $199+

Standard shipping is $8. Free at a $199 product subtotal before discounts.

Orders normally process within 3 business days. Shipping details

Live stock checkPrice and availability verify again before checkout.
COA supportRequest lot documentation before or after ordering.
Pay with PayPalPayPal receives an order code, not product names.

The mg amount is the compound quantity. Vial capacity (mL) is the container size, not a prepared concentration.

Format
3 mL clear glass vial
Documentation
Ask us for the available lot-specific COA before ordering.
Catalog status
In stock

Product options and research links

Also listed as Retatrutide peptide 20mg and Reta peptide 20mg.

Review related strengths, the research-area directory, and the documentation resources connected to this catalog record.

Research use onlyNot for human or veterinary consumption.
Back to catalog

Vial specifications

Core technical information at a glance.

Strength
20 mg
Container
3 mL clear glass vial
Format
Lyophilized
Classification
Research use only

Documentation

Check the lot documentation.

Ask which certificate of analysis is available for your product and lot before ordering.

Request COARead documentation guide

Technical overview

Research context

Review the research background and laboratory handling information for this product. Research findings do not establish safety or effectiveness for human use.

Product overview

Retatrutide (GLP3-R) 20mg is the 20 mg catalog presentation. Retatrutide, identified as LY3437943 in publications, is studied at GLP-1, GIP and glucagon receptors. GLP3-R is a catalog alias, not a different chemical identity.

Reference context and limits

The 2022 discovery study includes receptor assays. A 2024 structural study examines retatrutide-bound receptor complexes.

Published investigational preparations are not interchangeable with this research-only vial. Confirm chemical form, modifications and analytical identity before comparing materials. Neither receptor findings nor clinical results establish this vial's safety or performance.

Product details

Catalog material: Peptide
Labeled quantity: 20 mg
Exact product record: Retatrutide (GLP3-R) 20mg

The listed quantity is a catalog label, not a dosing instruction, concentration, measured-content result or purity percentage.

Documentation checks

Use the documentation request form with the exact product and lot when asking which records are available. Read the HPLC and mass-spectrometry guide to distinguish identity, chromatographic purity and content measurements.

Handling information

Storage and stability depend on the documented material, formulation and conditions. Follow the applicable supplier documentation and your laboratory's approved procedures. This page does not specify a universal storage temperature, solvent or prepared-material lifetime.

Reference sources

Reference links checked . This is a source-link review, not certification or lot testing. Report a product-information correction.

Other catalog quantities

Related quantities share this reference context, not a claim of different biological effects.

Research use only

For lawful laboratory research only. Not for human or veterinary use, personal consumption, diagnosis or treatment. A publication discussing a medicine does not change the restrictions on this catalog material. Review the research-use policy.